National
Gay mayor-elect vows to ‘clean up’ Atlantic City
Republican beat incumbent with support from Democrats
Don Guardian shocked Atlantic City’s political establishment by defeating the Democratic incumbent earlier this month. (Photo courtesy of Guardian)
Don Guardian said he never became involved in politics until recently when he “got fed up with how bad things were” in his hometown of Atlantic City, New Jersey.
Guardian, 60, a gay Republican, ran for mayor this year in the Nov. 5 election. He shocked Atlantic City’s political establishment by defeating incumbent Mayor Lorenzo Langford, a Democrat, in a city where Democrats outnumber Republicans among registered voters by a nine to one margin.
“I said I thought we needed to bring all of the different groups within Atlantic City together,” Guardian told the Blade. “And that extended to race, color, creed, national origin, political parties, sexual orientation and gender.”
For the past 21 years, Guardian has worked as executive director of the Atlantic City Improvement District, a non-profit corporation recently acquired by the state government that provides services to the city’s tourism district where more than a dozen casinos and upscale hotels are located.
Guardian said he believes he succeeded in defining himself as a good-government reform candidate capable of using his knowledge and experience in running the tourism district to address the longstanding problems plaguing the rest of the city, where most of the residents live.
“From a city standpoint the services are very, very poor,” he said. “From not cleaning the streets or replacing lights, paving roads, maintaining parks and playgrounds, cleaning beaches, maintaining the boardwalk – services that you would expect from a city to be commonplace – are not,” he said.
“And yet we have the third highest budget in the State of New Jersey. Only Newark and Jersey City are larger than us,” he said. “And we have the largest workforce in the state.”
Added Guardian, “I ran on a platform that I was going to bring those services to the other half of the city that was not receiving them.”
Pointing to his promise to limit his tenure in office to two terms, Guardian said he also “ran on a campaign that I needed eight years to clean up this city, to bring development back, to bring housing back, to bring up the standards, to lower taxes and to reduce crime.”
To the surprise of many of the city’s political observers, he attracted the support of constituency groups that traditionally back Democratic candidates, including a key local labor union and Latino and Asian-Pacific Islander advocacy groups.
Also on his agenda, he said, are plans to strengthen efforts already under way to promote Atlantic City as an entertainment and beach destination in addition to its well-known reputation as a center for casino gambling. With many other states legalizing casino gambling, Atlantic City no longer has an East Coast monopoly on gaming, Guardian said, making it essential that the city “reinvent itself” as a destination with attractions other than gaming.
Among the groups that endorsed Guardian were the International Brotherhood of Electrical Workers, the Latino Leadership Alliance of New Jersey, and the Pakistani-American Muslim Organization of South Jersey.
Guardian said rank-and-file Democrats clearly crossed over to vote for him following what he says was an aggressive grassroots campaign in which he knocked on the doors of more than 3,000 homes to listen to what people’s concerns were.
“There’s no question – Democrats and independents are the reason that I’m the mayor-elect today,” he said. “They provided the majority of my volunteers, the majority of the funding.”
Following a recount and careful examination of mail-in and provisional ballots counted during a 10-day period after the Nov. 5 election, the Atlantic County Board of Elections last week issued its final vote count in the mayoral race.
Guardian received 3,929 votes compared to Langford, who received 3,568 votes, showing Guardian won by a razor-thin 361-vote margin. An independent candidate, John McQueen, received 230 votes.
Although Guardian beat Langford by a close margin, election results show he received 1,032 more votes in Atlantic City than Gov. Chris Christie, who won his statewide re-election bid by a landslide.
In Democratic dominated Atlantic City, Democratic State Sen. Barbara Buono beat Christie, a Republican, by a vote of 4,293 to 2,897. In the statewide vote, Christie trounced Buono by a margin of 60 percent to 38 percent, catapulting him into the national spotlight as a possible presidential candidate in 2016.
Guardian said that although he has yet to meet Christie, the governor initiated policies in his first term to boost economic development efforts in Atlantic City. He said he looks forward to an amicable relationship with the Christie administration.
Most political observers said Langford’s relationship with Christie became strained last year when he and Christie clashed over an evacuation plan for Atlantic City during the onset of Tropical Storm Sandy, which devastated much of the Southern New Jersey coast.
Guardian, in describing himself as a political newcomer, said he was unaware of the existence of the Gay and Lesbian Victory Fund, a national political organization that raises money for openly LGBT candidates running for public office. Had he applied for and received an endorsement from the Victory Fund, he could have received additional financial support for his campaign.
“I have to tell you I was very naïve in not knowing there was such a thing as organized gay, lesbian, transgender support, either financial or otherwise,” he said. “And so no, I never applied and no one contacted me.”
Gregory Angelo, president of the Log Cabin Republicans, said there is no state Log Cabin organization in New Jersey, which prevented Log Cabin from endorsing Guardian under the group’s bylaws.
“I had my eye on this but we were not involved,” Angelo told the Blade. “But the fact that we have an elected gay Republican is a good thing.”
While he had few connections with LGBT organizations, Guardian said he supported LGBT equality during his tenure with the Atlantic City Special Improvement District, which he said adopted its own internal non-discrimination policy for LGBT employees.
As a longtime member and leader of the Rotary Clubs of Southern New Jersey, Guardian said he and his partner of 19 years, Louis Fatato, used the occasion of Guardian’s 2005 induction ceremony as district governor of the Rotary International organization of South Jersey to formally announce they had legally filed for a domestic partnership.
“It was great for us to announce it,” he said. “This was a great day for Rotary and for me personally. I have a domestic partnership and I’m also being inducted as a governor of Rotary International.”
During this year’s mayoral campaign, Guardian said he expressed his support for same-sex marriage in New Jersey in response to a question presented to him and Langford during a candidate debate.
“He said that was a national issue and he was a Christian and everybody has their own views,” said Guardian. “My response was the courts have made it very clear that gay marriage is a civil rights issue and that I would always stand on the right side of civil rights.”
Added Guardian: “In other words, I’m not supporting it because I’m a gay guy. I’m supporting it because the courts have already ruled that New Jersey has to provide gay marriage and that our current domestic partnership is not the same as civil marriage and therefore it had to be changed.”
According to Guardian, Langford never raised Guardian’s sexual orientation directly on the campaign trail in his public statements. But Guardian said a letter that the Langford campaign sent to voters urged voters to ask Guardian about “his unacceptable lifestyle.”
Neither Langford’s office nor his campaign responded to a request from the Blade for comment on this and other issues surrounding the campaign.
Similarly, the Atlantic County Democratic Party Chair, James Schroeder, and the county’s Republican Party Chair, Keith Davis, did not return calls seeking comment on Guardian’s election as mayor. Atlantic City is located within Atlantic County.
Also not responding to calls from the Blade for comment on Guardian’s election were spokespersons for Christie.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
